Sub Banner Image

AstraZeneca’s US listing to leave £200mn UK stamp duty hole

Business & Finance

·

October 2, 2025

·

Financial Times

HMRC will no longer reap benefit of share trading in FTSE 100’s largest company

More from

Financial Times

More

Business & Finance

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.